These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 29731621)
1. Physical inactivity is associated with decreased growth differentiation factor 11 in chronic obstructive pulmonary disease. Tanaka R; Sugiura H; Yamada M; Ichikawa T; Koarai A; Fujino N; Yanagisawa S; Onodera K; Numakura T; Sato K; Kyogoku Y; Sano H; Yamanaka S; Okazaki T; Tamada T; Miura M; Takahashi T; Ichinose M Int J Chron Obstruct Pulmon Dis; 2018; 13():1333-1342. PubMed ID: 29731621 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal Relationship Between Growth Differentiation Factor 11 and Physical Activity in Chronic Obstructive Pulmonary Disease. Tanaka R; Koarai A; Yamada M; Fujino N; Ichikawa T; Numakura T; Onodera K; Kyogoku Y; Tamada T; Miura M; Minakata Y; Ichinose M; Sugiura H Int J Chron Obstruct Pulmon Dis; 2021; 16():999-1006. PubMed ID: 33883893 [TBL] [Abstract][Full Text] [Related]
3. Relationship of Circulating Growth and Differentiation Factors 8 and 11 and Their Antagonists as Measured Using Liquid Chromatography-Tandem Mass Spectrometry With Age and Skeletal Muscle Strength in Healthy Adults. Semba RD; Zhang P; Zhu M; Fabbri E; Gonzalez-Freire M; Carlson OD; Moaddel R; Tanaka T; Egan JM; Ferrucci L J Gerontol A Biol Sci Med Sci; 2019 Jan; 74(1):129-136. PubMed ID: 30380014 [TBL] [Abstract][Full Text] [Related]
4. Decrease in an anti-ageing factor, growth differentiation factor 11, in chronic obstructive pulmonary disease. Onodera K; Sugiura H; Yamada M; Koarai A; Fujino N; Yanagisawa S; Tanaka R; Numakura T; Togo S; Sato K; Kyogoku Y; Hashimoto Y; Okazaki T; Tamada T; Kobayashi S; Yanai M; Miura M; Hoshikawa Y; Okada Y; Suzuki S; Ichinose M Thorax; 2017 Oct; 72(10):893-904. PubMed ID: 28455454 [TBL] [Abstract][Full Text] [Related]
5. Relationship of muscle function to circulating myostatin, follistatin and GDF11 in older women and men. Fife E; Kostka J; Kroc Ł; Guligowska A; Pigłowska M; Sołtysik B; Kaufman-Szymczyk A; Fabianowska-Majewska K; Kostka T BMC Geriatr; 2018 Aug; 18(1):200. PubMed ID: 30165829 [TBL] [Abstract][Full Text] [Related]
6. Reduced expression of growth differentiation factor 11 promoted the progression of chronic obstructive pulmonary disease by activating the AKT signaling pathway. Tang F; Ling C; Liu J Biomed Pharmacother; 2018 Jul; 103():691-698. PubMed ID: 29680737 [TBL] [Abstract][Full Text] [Related]
7. Home-based pulmonary rehabilitation improves clinical features and systemic inflammation in chronic obstructive pulmonary disease patients. do Nascimento ES; Sampaio LM; Peixoto-Souza FS; Dias FD; Gomes EL; Greiffo FR; Ligeiro de Oliveira AP; Stirbulov R; Vieira RP; Costa D Int J Chron Obstruct Pulmon Dis; 2015; 10():645-53. PubMed ID: 25848241 [TBL] [Abstract][Full Text] [Related]
8. Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients. Ferrari R; Caram LM; Faganello MM; Sanchez FF; Tanni SE; Godoy I Int J Chron Obstruct Pulmon Dis; 2015; 10():1553-8. PubMed ID: 26345641 [TBL] [Abstract][Full Text] [Related]
9. Gait characteristics and their associations with clinical outcomes in patients with chronic obstructive pulmonary disease. Iwakura M; Okura K; Shibata K; Kawagoshi A; Sugawara K; Takahashi H; Shioya T; Wakasa M Gait Posture; 2019 Oct; 74():60-65. PubMed ID: 31470225 [TBL] [Abstract][Full Text] [Related]
10. Is iron deficiency modulating physical activity in COPD? Martín-Ontiyuelo C; Rodó-Pin A; Sancho-Muñoz A; Martinez-Llorens JM; Admetlló M; Molina L; Gea J; Barreiro E; Chiaradía DAR Int J Chron Obstruct Pulmon Dis; 2019; 14():211-214. PubMed ID: 30666101 [TBL] [Abstract][Full Text] [Related]
11. Sarcopenia correlates with systemic inflammation in COPD. Byun MK; Cho EN; Chang J; Ahn CM; Kim HJ Int J Chron Obstruct Pulmon Dis; 2017; 12():669-675. PubMed ID: 28255238 [TBL] [Abstract][Full Text] [Related]
12. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Sinha M; Jang YC; Oh J; Khong D; Wu EY; Manohar R; Miller C; Regalado SG; Loffredo FS; Pancoast JR; Hirshman MF; Lebowitz J; Shadrach JL; Cerletti M; Kim MJ; Serwold T; Goodyear LJ; Rosner B; Lee RT; Wagers AJ Science; 2014 May; 344(6184):649-52. PubMed ID: 24797481 [TBL] [Abstract][Full Text] [Related]
13. Increased serum GDF11 concentration is associated with a high prevalence of osteoporosis in elderly native Chinese women. Jin M; Song S; Guo L; Jiang T; Lin ZY Clin Exp Pharmacol Physiol; 2016 Nov; 43(11):1145-1147. PubMed ID: 27557752 [TBL] [Abstract][Full Text] [Related]
15. Serum growth differentiation factor 11 is closely related to metabolic syndrome in a Chinese cohort. Xu B; Huang Y; Zhang R; Tang M; He Z; Jin L; Zong Y; Hu C; Jia W J Diabetes Investig; 2021 Feb; 12(2):234-243. PubMed ID: 32592621 [TBL] [Abstract][Full Text] [Related]
16. Factors associated with impairment of quadriceps muscle function in Chinese patients with chronic obstructive pulmonary disease. Ju C; Chen R PLoS One; 2014; 9(2):e84167. PubMed ID: 24558357 [TBL] [Abstract][Full Text] [Related]
17. Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease. Romme EA; Rutten EP; Smeenk FW; Spruit MA; Menheere PP; Wouters EF Ann Med; 2013 Feb; 45(1):91-6. PubMed ID: 22462562 [TBL] [Abstract][Full Text] [Related]
18. Identification of Phenotypes in People with COPD: Influence of Physical Activity, Sedentary Behaviour, Body Composition and Skeletal Muscle Strength. Xavier RF; Pereira ACAC; Lopes AC; Cavalheri V; Pinto RMC; Cukier A; Ramos EMC; Carvalho CRF Lung; 2019 Feb; 197(1):37-45. PubMed ID: 30430249 [TBL] [Abstract][Full Text] [Related]
19. Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD. Li D; Wu Y; Guo S; Qin J; Feng M; An Y; Zhang J; Li Y; Xiong S; Zhou H; Zeng Q; Chen L; Wen F Int J Chron Obstruct Pulmon Dis; 2019; 14():1933-1941. PubMed ID: 31695352 [TBL] [Abstract][Full Text] [Related]
20. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease. Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]